These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo. Thorpe PE, Brown AN, Bremner JA, Foxwell BM, Stirpe F. J Natl Cancer Inst; 1985 Jul 01; 75(1):151-9. PubMed ID: 3859688 [Abstract] [Full Text] [Related]
18. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain. Ramakrishnan S, Houston LL. Cancer Res; 1984 Apr 15; 44(4):1398-404. PubMed ID: 6142765 [Abstract] [Full Text] [Related]
19. Tumor necrosis treatment of ME-180 human cervical carcinoma model with 131I-labeled TNT-1 monoclonal antibody. Chen FM, Taylor CR, Epstein AL. Cancer Res; 1989 Aug 15; 49(16):4578-85. PubMed ID: 2743341 [Abstract] [Full Text] [Related]
20. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies. Blumenthal RD, Sharkey RM, Haywood L, Natale AM, Wong GY, Siegel JA, Kennel SJ, Goldenberg DM. Cancer Res; 1992 Nov 01; 52(21):6036-44. PubMed ID: 1394228 [Abstract] [Full Text] [Related] Page: [Next] [New Search]